Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in COVID 19 vaccine

We Will Soon Rollout Our Own Vaccine In Israel, Says Boaz Lev, Head Of Israel Vaccine Task Force

Israel has managed to successfully control the Covid-19 pandemic, whereas India is battling a second wave of the pandemic. Mutations of the virus have perplexed the scientists in the country and raised concern over the efficacy of vaccine against Covid. Israel’s story is important for their approach. Dr. Boaz Lev, Israel’s head of Advisory Committee for Corona Vaccines and Epidemic Control and former Director General of its Administration of Health, in an exclusive interaction with BW Businessworld’s Manish Kumar Jha, talks about his country’s approach and it managed overcome the issues surrounding the pandemic. Excerpts:

Read More

Remdesivir Production Expected To Start In Wardha From Wednesday

Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalised with severe disease.

Read More

Govt Working Hard To Enhance Production Of Remdesivir: Mandaviya

The government had waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug in order to help augment domestic availability and reduce the cost of the injection.

Read More

VAV Lifesciences To Supply Key COVID Vaccine Ingredient To Pfizer, Moderna

The US firm will use the lipids made by VAV to produce gene-based lipid nanoparticles on behalf of the brand owners -- Pfizer-BioNTech and Moderna.

Read More

Wall Street Rallies On US Stimulus And Vaccine Hopes As Bond Markets Calm

Emerging market stocks rose 1.71%. MSCI's broadest index of Asia-Pacific shares outside Japan closed 1.83% higher, while Japan's Nikkei rose 2.41%.

Read More

Pfizer Sees About $15 Billion In 2021 Sales From COVID-19 Vaccine

The vaccine was among the first to be authorized for emergency use in the United States and several other countries, and analysts have forecast billions in sales.

Read More

J&J Vaccine Adds To COVID-19 Armoury, Includes South African Variant

J&J shares were down 4% at $162.7 at 1700 GMT, with some Wall Street analysts saying its vaccine's effectiveness was below those of rivals. Moderna's stock gained 8% to $172.80.

Read More

Going Ahead Stronger

The vaccination team at each centre will have five members, two security personnel to validate the identity of the beneficiary and three nurses to vaccinate and observe the healthcare professional after the process is complete.

Read More

UNICEF Signs Up Dubai's DP World To Help Distribute COVID-19 Vaccines

State-owned DP World, known for its global port operations, will provide transport and storage to UNICEF at no cost, helping low and middle-income countries access vaccines

Read More

Europe Prepares For Moderna Vaccine Rollout As Fears Grow Over Virus Variants

Moderna shares were up more than 4% in early New York trading. The company's value has surged more than 450% since February last year as the pandemic gripped the world and drugmakers rushed to develop shots.

Read More

DGCI Approves The Vaccines By Serum Institute Of India And Bharat Biotech

Both the vaccines can be stored at 2-8 degrees, and the companies have been stockpiling of over 50 million doses at the moment, assuring that soon they will be manufacturing more dosage of the vaccine.

Read More

India Drug Regulator Meets To Discuss Astrazeneca Vaccine

India wants to start administering the shots starting next month and is also considering emergency use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech and by India's Bharat Biotech.

Read More

World Stocks Ease Further From Highs, Oil Dips On COVID-19 Count

At 1053 GMT, the broad gauge of global equities was trading down 0.4% while Europe's major indexes were down 0.8%-1%. Oil prices also fell 1-1.6% as virus restrictions crimped demand expectations.

Read More

J&J Starts Two-Dose Trial Of Its COVID-19 Candidate Vaccine In The UK

J&J signed an agreement for the two-dose global Phase III clinical trial with the British government in August, to run in parallel with a 60,000-person trial of a single shot of the experimental vaccine which was launched in September.

Read More

Asian Shares Rise On Vaccine Bets But Analysts Urge Caution

MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.44%, approaching the highest since January 2018. Chinese shares rose 0.37%. Stocks in Japan rose 0.62% to a 29-year high.

Read More